6076 - 6100 of 6230 Results
Title
Year
-
OPENTitle: Structural Characterization of LRRK2 InhibitorsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 9Start Page: 3751End Page: 3756Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm5018779Best OA location URL: https://research.rug.nl/en/publications/5c2dfd00-1285-4fd7-a819-6b338c56d5a8Citation Count: 38
- Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s Disease2022OPENTitle: Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 13985End Page: 13985Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232213985Best OA location URL: https://www.mdpi.com/1422-0067/23/22/13985/pdf?version=1668767894Citation Count: 10
- Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice2021OPENTitle: Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in miceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-24567-xBest OA location URL: https://escholarship.org/uc/item/35j6s17tCitation Count: 9
- Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's disease2018OPENTitle: Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 11Issue #: 6Start Page: 1404End Page: 1406Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2018.08.016Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X18302997/pdfCitation Count: 9
-
OPENTitle: LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorderJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 52Issue #:Start Page: 98End Page: 101Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.03.019Best OA location URL: http://hdl.handle.net/11380/1206056Citation Count: 32
-
OPENTitle: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/564812Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/564812.pdfCitation Count: 4
- Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)2016OPENTitle: Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)Journal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1192End Page: 1200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00035Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00035Citation Count: 44
- Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation2025OPENTitle: Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestationJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 4Start Page: 766End Page: 779Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251328567Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1877718X251328567Citation Count: 0
-
OPENTitle: Automated Quality Control for Sensor Based Symptom Measurement Performed Outside the LabJournal Name: SensorsPublisher: MDPI AGVol: 18Issue #: 4Start Page: 1215End Page: 1215Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s18041215Best OA location URL: https://www.mdpi.com/1424-8220/18/4/1215/pdf?version=1525348690Citation Count: 22
- Kinetics of alpha-synuclein depletion in three brain regions following conditional pan-neuronal inactivation of the encoding gene (Snca) by tamoxifen-induced Cre-recombination in adult mice2021OPENTitle: Kinetics of alpha-synuclein depletion in three brain regions following conditional pan-neuronal inactivation of the encoding gene (Snca) by tamoxifen-induced Cre-recombination in adult miceJournal Name: Transgenic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 6Start Page: 867End Page: 873Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11248-021-00286-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11248-021-00286-3.pdfCitation Count: 3
- Study protocol for the Heads-Up trial: a phase II randomized controlled trial investigating head-up tilt sleeping to alleviate orthostatic intolerance in Parkinson’s Disease and parkinsonism2024OPENTitle: Study protocol for the Heads-Up trial: a phase II randomized controlled trial investigating head-up tilt sleeping to alleviate orthostatic intolerance in Parkinson’s Disease and parkinsonismJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03506-xBest OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03506-xCitation Count: 1
- Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor2015OPENTitle: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 6Issue #: 5Start Page: 584End Page: 589Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064Best OA location URL: http://doi.org/10.1021/acsmedchemlett.5b00064Citation Count: 50
- Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairment2024OPENTitle: Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairmentJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae453Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae453/61218229/fcae453.pdfCitation Count: 2
- Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signalling2023OPENTitle: Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signallingJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 9Start Page: 3676End Page: 3689Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad162Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad162/50350389/awad162.pdfCitation Count: 13
- Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease2016OPENTitle: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00271/pdfCitation Count: 7
-
OPENTitle: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 163End Page: 169Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/111216027/The_role_of_phosphodiesterase_WILSON_Accepted18February2019_GREEN_AAM.pdfCitation Count: 15
- Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique Study2021OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 22
-
OPENTitle: New Developments in Cholinergic Imaging in Alzheimer and Lewy Body DisordersJournal Name: Current Behavioral Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 278End Page: 286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s40473-020-00221-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7992054Citation Count: 8
- Tandem Ring Opening/Intramolecular [2 + 2] Cycloaddition Reaction for the Synthesis of Cyclobutane Fused Thiazolino-2-Pyridones2021OPENTitle: Tandem Ring Opening/Intramolecular [2 + 2] Cycloaddition Reaction for the Synthesis of Cyclobutane Fused Thiazolino-2-PyridonesJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 86Issue #: 23Start Page: 16582End Page: 16592Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.joc.1c01875Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.joc.1c01875Citation Count: 2
- MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulation2025OPENTitle: MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-025-95679-3Best OA location URL: https://www.nature.com/articles/s41598-025-95679-3.pdfCitation Count: 0
- A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults2025OPENTitle: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251356503Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1877718X251356503Citation Count: 0
- Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology2021OPENTitle: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathologyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 3Start Page: 1001End Page: 1017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab374Best OA location URL: https://academic.oup.com/brain/article-pdf/145/3/1001/43500027/awab374.pdfCitation Count: 20
-
OPENTitle: LRP1: a novel receptor for the transmission of pathological α-SynucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00582-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00582-4Citation Count: 1
- Profiling Protein–Protein Interactions in the Human Brain by Refined Cofractionation Mass Spectrometry2024OPENTitle: Profiling Protein–Protein Interactions in the Human Brain by Refined Cofractionation Mass SpectrometryJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 23Issue #: 4Start Page: 1221End Page: 1231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.3c00685Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11065482Citation Count: 1
- LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons2021OPENTitle: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neuronsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 1020End Page: 1048Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2021.1967615Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1967615?needAccess=trueCitation Count: 41